Publication:
Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach.

No Thumbnail Available

Date

2022-07-13

Authors

Barrios, Vivencio
Cinza-Sanjurjo, Sergio
García-Alegría, Javier
Freixa-Pamias, Román
Llordachs-Marques, Frederic
Molina, Carlos A
Santamaría, Amparo
Vivas, David
Suárez Fernandez, Carmen

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Compared with face-to-face consultations, telemedicine has many advantages, including more efficient use of healthcare resources, partial relief of the burden of care, reduced exposure to COVID-19, treatment adjustment, organization of more efficient healthcare circuits and patient empowerment. Ensuring optimal anticoagulation in atrial fibrillation patients is mandatory if we want to reduce the thromboembolic risk. Of note, telemedicine is an excellent option for the long-term management of atrial fibrillation patients. Moreover, direct oral anticoagulants may provide an added value in telemedicine (versus vitamin K antagonists), as it is not necessary to monitor anticoagulant effect or make continuous dosage adjustments. In this multidisciplinary consensus document, the role of telemedicine in anticoagulation of this population is discussed and practical recommendations are provided.

Description

MeSH Terms

Administration, Oral
Anticoagulants
Atrial Fibrillation
COVID-19
Humans
Stroke
Telemedicine

DeCS Terms

CIE Terms

Keywords

COVID-19, anticoagulation, atrial fibrillation, direct oral anticoagulant, telemedicine, vitamin K antagonist

Citation